Table 3. Dydrogesterone utilization pattern: indications, frequency, dosage, dosing regime (timing).
| Indications for dydrogesterone | |
|---|---|
| n=7287 | n(%) |
| Obstetric conditions | |
| Threatened abortion | 3421(46.9) |
| Recurrent pregnancy loss | 1986(27.3) |
| Gynecological causes | |
| Infertility due to luteal phase insufficiency | 843(11.6) |
| Luteal phase support as a part of ART treatment | 750(10.3) |
| Dysfunctional uterine bleeding | 235(3.2) |
| Endometriosis | 208(2.9) |
| Secondary Amenorrhea | 79(1.1) |
| Hormone replacement therapy | 74(1) |
| Loading dose, dosing frequency, dosing regime (timing) | |
| n=7287 | n(%) |
| Loading dose prescribed | 2007(27.5) |
| No loading dose prescribed | 5280(72.5) |
| Loading dose prescribed (n=2007) | |
| 20 mg | 387(19.3) |
| 30 mg | 318(15.8) |
| 40 mg | 1285(64.0) |
| 50 mg | 3(0.1)% |
| 60 mg | 13(0.6)% |
| 80 mg | 1(0.0)% |
| Maintenance dose/starting without loading dose (n=5280) | |
| 10 mg | 4299(81.4) |
| 20 mg | 770(14.6) |
| 30 mg | 134(2.5) |
| 40 mg | 72(1.4) |
| 50 mg | 4(0.08) |
| 60 mg | 1(0.02) |
| Dosing frequency (n=6851) | |
| OD | 869(12.7) |
| BID | 4562(66.6) |
| TID | 1420(20.7) |
| Dosing regimen (n=7286) | |
| Morning | 5744(78.8) |
| Afternoon | 1381(19) |
| Evening | 5706(78.3) |
| Cyclical/continuous (n=4791) | |
| Cyclical Treatment | 1072(22.4) |
| Continuous Treatment | 3719(77.6) |